Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Aug 30, 2024

SELL
$0.67 - $1.51 $10,251 - $23,103
-15,300 Closed
0 $0
Q2 2021

Aug 30, 2024

BUY
$0.75 - $1.1 $11,475 - $16,830
15,300 New
15,300 $11.9 Million
Q4 2020

Aug 30, 2024

BUY
$0.76 - $1.47 $11,628 - $22,491
15,300 New
15,300 $20.8 Million

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.